CIIC Fall 2024 Conference
Sep 13 - Sep 14, 2024
- Title: Long-Term Efficacy and Safety of Oral Deucrictibant, a Bradykinin B2 Receptor Antagonist, in Treatment of Hereditary Angioedema Attacks: Results of the RAPIDe-2 Extension Study
Presenter: Joshua S. Jacobs, M.D.
Format: ePoster
Date/Time: Saturday, September 14, 10:15-11:00 a.m. CDT - Title: Long-Term Safety and Efficacy of Prophylactic Oral Deucrictibant, a Bradykinin B2 Receptor Antagonist, in Hereditary Angioedema: Results of the CHAPTER-1 Open Label Extension Study
Format: Looped e-Poster Display Board